MURAL - Maynooth University Research Archive Library



    Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2


    Reading, James and Vaes, Bart and Hull, Caroline and Sabbah, Shereen and Hayday, Thomas and Wang, Nancy S. and DiPiero, Anthony and Lehman, Nocolas A. and Taggart, Jen M. and Carty, Fiona and English, Karen and Pinxteren, Jef and Deans, Robert and Ting, Anthony E. and Tree, Timothy (2015) Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2. Molecular Therapy, 23 (11). pp. 1783-1793. ISSN 1525-0016

    [img]
    Preview
    Download (1MB) | Preview


    Share your research

    Twitter Facebook LinkedIn GooglePlus Email more...



    Add this article to your Mendeley library


    Abstract

    T-cell depletion therapy is used to prevent acute allograft rejection, treat autoimmunity and create space for bone marrow or hematopoietic cell transplantation. The evolved response to T-cell loss is a transient increase in IL-7 that drives compensatory homeostatic proliferation (HP) of mature T cells. Paradoxically, the exaggerated form of this process that occurs following lymphodepletion expands effector T-cells, often causing loss of immunological tolerance that results in rapid graft rejection, autoimmunity, and exacerbated graft-versus-host disease (GVHD). While standard immune suppression is unable to treat these pathologies, growing evidence suggests that manipulating the incipient process of HP increases allograft survival, prevents autoimmunity, and markedly reduces GVHD. Multipotent adult progenitor cells (MAPC) are a clinical grade immunomodulatory cell therapy known to alter γ-chain cytokine responses in T-cells. Herein, we demonstrate that MAPC regulate HP of human T-cells, prevent the expansion of Th1, Th17, and Th22 effectors, and block the development of pathogenic allograft responses. This occurs via IL-1β- primed secretion of PGE2 and activates T-cell intrinsic regulatory mechanisms (SOCS2, GADD45A). These data provide proof-of-principle that HP of human T-cells can be targeted by cellular and molecular therapies and lays a basis for the development of novel strategies to prevent immunopathology in lymphodepleted patients.

    Item Type: Article
    Keywords: Suppression; IL-7-dependent Effector T-cell Expansion; Multipotent Adult Progenitor Cells; PGE2;
    Academic Unit: Faculty of Science and Engineering > Biology
    Item ID: 10580
    Identification Number: https://doi.org/10.1038/mt.2015.131
    Depositing User: Karen English
    Date Deposited: 25 Feb 2019 12:20
    Journal or Publication Title: Molecular Therapy
    Publisher: Elsevier
    Refereed: Yes
    URI:

    Repository Staff Only(login required)

    View Item Item control page

    Downloads

    Downloads per month over past year